Lifetime adiposity and risk of pancreatic cancer in the NIH-AARP Diet and Health Study cohort

American Journal of Clinical Nutrition

Volumn 98, Issue 4, 2013, Pages 1057-1065

  Stolzenberg Solomon, Rachael Z ^a   Schairer, Catherine ^a   Moore, Steve ^a   Hollenbeck, Albert ^b   Silverman, Debra T ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b AARP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SATURATED FATTY ACID;

ADULT; ARTICLE; BODY MASS; CANCER RISK; DIABETES MELLITUS; DIETARY INTAKE; DISEASE DURATION; FAT INTAKE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PANCREAS ADENOCARCINOMA; PHYSICAL ACTIVITY; QUESTIONNAIRE; RED MEAT; SMOKING;

ADENOCARCINOMA; ADIPOSITY; ADOLESCENT; ADULT; AGE FACTORS; AGED; BODY MASS INDEX; COHORT STUDIES; DIET; FEMALE; HUMANS; MALE; MIDDLE AGED; NATIONAL INSTITUTES OF HEALTH (U.S.); OBESITY; OVERWEIGHT; PANCREATIC NEOPLASMS; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 84884864736     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.113.058123     Document Type: Article

References (50)

1. Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, Barzi F, Woodward M. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 2005;92:2076-83. (Pubitemid 40897433)
2. Stolzenberg-Solomon RZ, Graubard BI, Chari S, Limburg P, Taylor PR, Virtamo J, Albanes D. Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA 2005;294:2872-8. (Pubitemid 41785868)
3. Michaud DS, Wolpin B, Giovannucci E, Liu S, Cochrane B, Manson JE, Pollak MN, Ma J, Fuchs CS. Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 2007;16:2101-9. (Pubitemid 47621187)
4. Anderson KE, Mack TM, Silverman DT. Cancer of the Pancreas. In: Schottenfeld D, Fraumeni JF, eds. Cancer epidemiology and prevention. 3rd ed. New York, NY: Oxford University Press, 2006:721-63.
5. Li D, Morris JS, Liu J, Hassan MM, Day RS, Bondy ML, Abbruzzese JL. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA 2009;301:2553-62.
6. Schatzkin A, Subar AF, Thompson FE, Harlan LC, Tangrea J, Hollenbeck AR, Hurwitz PE, Coyle L, Schussler N, Michaud DS, et al. Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol 2001;154:1119-25. (Pubitemid 33140635)
7. Michaud DS, Midthune D, Hermansen S, Leitzmann M, Harlan LC, Kipnis V, Schatzkin A. Comparison of cancer registry case ascertainment with SEER estimates and self-reporting in a subset of the NIHAARP Diet and Health Study. J Registr Manag 2005;32:70-5.
8. WHO Expert Committee. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995;854:1-452.
9. Spiegelman D, Hertzmark E, Wand HC. Point and interval estimates of partial population attributable risks in cohort studies: examples and software. Cancer Causes Control 2007;18:571-9. (Pubitemid 46684817)
10. Lin G, So Y, Johnston G. Analyzing survival data with competing risks using SAS software. SAS Global Forum 2012. Cary, NC: SAS Institute, 2012.
11. Andersen PK, Geskus RB, de Witte T, Putter H. Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol 2012;41:861-70.
12. Eberle CA, Bracci PM, Holly EA. Anthropometric factors and pancreatic cancer in a population-based case-control study in the San Francisco Bay area. Cancer Causes Control 2005;16:1235-44. (Pubitemid 46179507)
13. Fryzek JP, Schenk M, Kinnard M, Greenson JK, Garabrant DH. The association of body mass index and pancreatic cancer in residents of southeastern Michigan, 1996-1999. Am J Epidemiol 2005;162:222-8. (Pubitemid 41373526)
14. Ji BT, Hatch MC, Chow WH, McLaughlin JK, Dai Q, Howe GR, Gao YT, Fraumeni JF Jr. Anthropometric and reproductive factors and the risk of pancreatic cancer: a case-control study in Shanghai, China. Int J Cancer 1996;66:432-7. (Pubitemid 26178166)
15. Urayama KY, Holcatova I, Janout V, Foretova L, Fabianova E, Adamcakova Z, Ryska M, Martinek A, Shonova O, Brennan P, et al. Body mass index and body size in early adulthood and risk of pancreatic cancer in a central European multicenter case-control study. Int J Cancer 2011;129:2875-84.
16. Patel AV, Rodriguez C, Bernstein L, Chao A, Thun MJ, Calle EE. Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. cohort. Cancer Epidemiol Biomarkers Prev 2005;14:459-66. (Pubitemid 40270112)
17. Michaud DS, Giovannucci E, Willett WC, Colditz GA, Stampfer MJ, Fuchs CS. Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA 2001;286:921-9. (Pubitemid 33010338)
18. Levi Z, Kark JD, Afek A, Derazne E, Tzur D, Furman M, Gordon B, Barchana M, Liphshitz I, Niv Y, et al. Measured body mass index in adolescence and the incidence of pancreatic cancer in a cohort of 720,000 Jewish men. Cancer Causes Control 2012;23:371-8.
19. Genkinger JM, Spiegelman D, Anderson KE, Bernstein L, van den Brandt PA, Calle EE, English DR, Folsom AR, Freudenheim JL, Fuchs CS, et al. A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer 2011;129:1708-17.
20. WCRF/AICR. Continuous update project for pancreatic cancer. World Cancer Research Fund 2012. Available from: http://www.dietandcancerreport. org/cup/current-progress/pancreatic-cancer.php (cited December 2012).
21. Bao B,Wang Z, Li Y, Kong D, Ali S, Banerjee S, Ahmad A, Sarkar FH. The complexities of obesity and diabetes with the development and progression of pancreatic cancer. Biochim Biophys Acta 2011;1815:135-46.
22. Gapstur SM, Gann PH, Lowe W, Liu K, Colangelo L, Dyer A. Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 2000;283:2552-8. (Pubitemid 30324198)
23. Stattin P, Bjor O, Ferrari P, Lukanova A, Lenner P, Lindahl B, Hallmans G, Kaaks R. Prospective study of hyperglycemia and cancer risk. Diabetes Care 2007;30:561-7. (Pubitemid 46354334)
24. Grote VA, Rohrmann S, Nieters A, Dossus L, Tjonneland A, Halkjaer J, Overvad K, Fagherazzi G, Boutron-Ruault MC, Morois S, et al. Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Diabetologia 2011;54:3037-46.
25. Grote VA, Rohrmann S, Dossus L, Nieters A, Halkjaer J, Tjonneland A, Overvad K, Stegger J, Chabbert-Buffet N, Boutron-Ruault MC, et al. The association of circulating adiponectin levels with pancreatic cancer risk: a study within the prospective EPIC cohort. Int J Cancer 2012;130:2428-37.
26. Hennig R, Ding XZ, Adrian TE. On the role of the islets of Langerhans in pancreatic cancer. Histol Histopathol 2004;19:999-1011. (Pubitemid 38855079)
27. Bell RH Jr, McCullough PJ, Pour PM. Influence of diabetes on susceptibility to experimental pancreatic cancer. Am J Surg 1988;155:159-64. (Pubitemid 18063541)
28. Pour PM, Kazakoff K, Carlson K. Inhibition of streptozotocin-induced islet cell tumors and N-nitrosobis(2-oxopropyl)amine-induced pancreatic exocrine tumors in Syrian hamsters by exogenous insulin. Cancer Res 1990;50:1634-9. (Pubitemid 20090484)
29. Pour PM, Stepan K. Modification of pancreatic carcinogenesis in the hamster model. VIII. Inhibitory effect of exogenous insulin. J Natl Cancer Inst 1984;72:1205-8.
30. Schneider MB, Matsuzaki H, Haorah J, Ulrich A, Standop J, Ding XZ, Adrian TE, Pour PM. Prevention of pancreatic cancer induction in hamsters by metformin. Gastroenterology 2001;120:1263-70. (Pubitemid 32246678)
31. Zyromski NJ, Mathur A, Gowda GA, Murphy C, Swartz-Basile DA, Wade TE, Pitt HA, Raftery D. Nuclear magnetic resonance spectroscopy- based metabolomics of the fatty pancreas: implicating fat in pancreatic pathology. Pancreatology 2009;9:410-9.
32. Decensi A, Puntoni M, Goodwin P, Cazzaniga M, Gennari A, Bonanni B, Gandini S. Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev Res (Phila) 2010;3: 1451-61.
33. Bodmer M, Becker C, Meier C, Jick SS, Meier CR. Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis. Am J Gastroenterol 2012;107:620-6.
34. Klopp AH, Zhang Y, Solley T, Amaya-Manzanares F, Marini F, Andreeff M, Debeb B, Woodward W, Schmandt R, Broaddus R, et al. Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors. Clin Cancer Res 2012;18:771-82.
35. Bellows CF, Zhang Y, Chen J, Frazier ML, Kolonin MG. Circulation of progenitor cells in obese and lean colorectal cancer patients. Cancer Epidemiol Biomarkers Prev 2011;20:2461-8.
36. Zhang Y, Daquinag A, Traktuev DO, Amaya-Manzanares F, Simmons PJ, March KL, Pasqualini R, Arap W, Kolonin MG. White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models. Cancer Res 2009;69:5259-66.
37. Berrington de Gonzalez A, Spencer EA, Bueno-de-Mesquita HB, Roddam A, Stolzenberg-Solomon R, Halkjaer J, Tjonneland A, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, et al. Anthropometry, physical activity, and the risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 2006;15:879-85. (Pubitemid 43823512)
38. Arslan AA, Helzlsouer KJ, Kooperberg C, Shu XO, Steplowski E, Bueno-de-Mesquita HB, Fuchs CS, Gross MD, Jacobs EJ, Lacroix AZ, et al. Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med 2010;170:791-802.
39. Stolzenberg-Solomon RZ, Adams K, Leitzmann M, Schairer C, Michaud DS, Hollenbeck A, Schatzkin A, Silverman DT. Adiposity, physical activity, and pancreatic cancer in the National Institutes of Health-AARP Diet and Health Cohort. Am J Epidemiol 2008;167:586-97. (Pubitemid 351323320)
40. Aune D, Greenwood DC, Chan DS, Vieira R, Vieira AR, Navarro Rosenblatt DA, Cade JE, Burley VJ, Norat T. Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. Ann Oncol 2012;23:843-52.
41. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999- 2010. JAMA 2012;307:491-7.
42. Verhage BA, Schouten LJ, Goldbohm RA, van den Brandt PA. Anthropometry and pancreatic cancer risk: an illustration of the importance of microscopic verification. Cancer Epidemiol Biomarkers Prev 2007;16:1449-54. (Pubitemid 47076877)
43. Klipstein-Grobusch K, Kroke A, Boeing H. Reproducibility of selfreported past body weight. Eur J Clin Nutr 1998;52:525-8. (Pubitemid 28330399)
44. Perry GS, Byers TE, Mokdad AH, Serdula MK, Williamson DF. The validity of self-reports of past body weights by U.S. adults. Epidemiology 1995;6:61-6.
45. Stevens J, Keil JE, Waid LR, Gazes PC. Accuracy of current, 4-year, and 28-year self-reported body weight in an elderly population. Am J Epidemiol 1990;132:1156-63.
46. Kovalchik S. Validity of adult lifetime self-reported body weight. Public Health Nutr 2009;12:1072-7.
47. Kyulo NL, Knutsen SF, Tonstad S, Fraser GE, Singh PN. Validation of recall of body weight over a 26-year period in cohort members of the Adventist Health Study 2. Ann Epidemiol 2012;22:744-6.
48. Norgan NG, Cameron N. The accuracy of body weight and height recall in middle-aged men. Int J Obes Relat Metab Disord 2000;24:1695-8.
49. Casey VA, Dwyer JT, Coleman KA, Krall EA, Gardner J, Valadian I. Accuracy of recall by middle-aged participants in a longitudinal study of their body size and indices of maturation earlier in life. Ann Hum Biol 1991;18:155-66.
50. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999- 2010. JAMA 2012;307:483-90.